The value of MRD as an early endpoint in multiple myeloma clinical trials VJHemOnc – Video Journal of Hematology & HemOnc 13,8 тыс. подписчиков Скачать
Unmet needs in high-risk multiple myeloma & important factors to consider when treating patients Скачать
Overcoming challenges with targeted therapies for CLL: high-risk mutations and BTKi resistance Скачать
Challenges with BTKi cardiotoxicity: what can be done to optimize long-term cardiac outcomes? Скачать
Factors to consider when selecting patients with multiple myeloma for treatment with bispecifics Скачать
The management of CLL in Nigeria: barriers and initiatives for improved understanding and care Скачать
The recent withdrawal of voxelotor from the market: the potential impact on patients with SCD Скачать
The use of golcadomide in combination with R-CHOP for the treatment of aggressive B-cell lymphomas Скачать
Using integrative multiomics to explain myeloma progression and evolution of refractory disease Скачать
Challenges and unmet needs in MPNs: transplant decision-making and the management of MPN-AP/BP Скачать
Prognostic and predictive biomarkers in CLL and their potential in guiding treatment decisions Скачать
Long-term survival of patients with CLL treated with ibrutinib compared to age-matched controls Скачать
The importance of understanding cellular functionality to develop biological therapies for CLL Скачать
Single-cell whole genome measurement of genomic heterogeneity and clonal evolution in myeloma Скачать
Results of a Phase I study of belantamab mafodotin in combination with KRd for treating myeloma Скачать
The value of early diagnosis in amyloidosis and the impact of a delayed diagnosis for patients Скачать
Current and future approaches to risk stratification in multiple myeloma: using dynamic models Скачать
Utilizing BCMA-targeting agents in elderly patients with myeloma: balancing efficacy & toxicity Скачать
A model including CD49d expression to predict outcomes in patients with CLL treated with ibrutinib Скачать
Factors to consider when choosing between cilta-cel & ide-cel for patients with multiple myeloma Скачать
Opportunities and challenges associated with implementing LLMs into medicine and clinical care Скачать
The potential of LLMs for accelerating scientific knowledge and our understanding of disease biology Скачать
Approaching patients with myeloma who are refractory to lenalidomide: challenges & future outlooks Скачать
OCEAN study updates: HRQoL in patients with R/R myeloma treated with melflufen + dexamethasone Скачать
Long-term follow-up of the GAIA/CLL13 trial: investigating venetoclax-containing combinations in CLL Скачать
The future of cancer medicine and the potential for personalized precision medicine using AI tools Скачать
Preventing and managing infections in patients with lymphoma treated with immunosuppressive therapy Скачать
Moving beyond JAK inhibitors: novel targets and pathways being explored for the treatment of MPNs Скачать
Important considerations when deciding whether a young patient with MPN should receive cytoreduction Скачать
Cardio-oncology guidelines for BTKi toxicities in CLL: how are they used in clinical practice? Скачать
Being more selective when choosing myeloma candidates for CAR-T therapy due to capacity issues Скачать
Optimizing treatment for Ph+ ALL: TKis combined with chemotherapy followed by transplantation Скачать
Treatment options for elderly CLL patients or those with comorbidities beyond BCL2 inhibitors Скачать
A CIBMTR study investigating the effect of donor type on transplantation outcomes in myelofibrosis Скачать
Unmet needs and areas of investigation in the treatment of pediatric and AYA patients with MPNs Скачать
Final results of a Phase II study of add-on parsaclisib for pts with MF and suboptimal rux response Скачать
Key takeaways from a panel discussion on interferon in MPNs: considering combination strategies Скачать
The global expansion of modern AML therapy through the International Consortium on Acute Leukemia Скачать
